title: Re: Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
authors.forename: R
authors.initials: R
authors.lastname: Gomperts
authors.forename: G
authors.initials: G
authors.lastname: Kleiverda
authors.forename: K
authors.initials: K
authors.lastname: Gemzell
authors.forename: S
authors.initials: S
authors.lastname: Davies
authors.forename: K
authors.initials: K
authors.lastname: Jelinska
mesh_terms: D000021:Abortifacient Agents, Steroidal / Q000600:supply & distribution*; D000028:Abortion, Induced / Q000379:methods*; D005260:Female; D006297:Health Services Accessibility / Q000592:standards; D006801:Humans; D015735:Mifepristone / Q000600:supply & distribution*; D016595:Misoprostol / Q000600:supply & distribution*; D011247:Pregnancy; D017216:Telemedicine / Q000706:statistics & numerical data*
chemical_list: D000021:Abortifacient Agents, Steroidal; D016595:Misoprostol; D015735:Mifepristone